Ovarian cancer drug mirvetuximab improves quality of life for patients, UK women report
By
James Gallagher
Needed another two minutes in the oven. A half-baked bagel.
Summary
A new ovarian cancer drug called mirvetuximab is offering women more time and a better quality of life compared to standard chemotherapy. Patricia, a patient from north London diagnosed in 2023, reports significantly reduced side effects like fatigue and nausea, allowing her to resume normal activities such as attending shows, dining out, and visiting family. The drug is described as a "game changer" by patients who say it has given them their lives back.
Key quotes
· 3 pulledShe said the difference was like night and day, and the therapy had given her 'a lot of my life back'.
She felt less tired and sick than when treated with standard chemotherapy, so felt 'a lot better' and describes the drug as a 'bit of a game changer'.
Women taking the drug tell the BBC it has given them their lives back.
You might also wanna read
Daily pill daraxonrasib doubles survival in advanced pancreatic cancer, clinical trial shows
A clinical trial has shown that a daily pill called daraxonrasib can double survival time for patients with advanced pancreatic cancer, one
theguardian.com·4d ago
Study Finds GLP-1 Drugs Associated with 58% Lower Mortality in Colon Cancer Patients
A study analyzing over 6,800 colon cancer patients across University of California Health sites found that patients taking GLP-1 medications
Engineered immunotherapy drug eliminates aggressive metastatic cancers in clinical trial
Researchers at Rockefeller University have developed an engineered CD40 agonist antibody that successfully eliminated aggressive metastatic
rockefeller.edu·8mo ago
Oregon State University Researchers Develop Iron Nanomaterial That Selectively Destroys Cancer Cells
Researchers at Oregon State University have developed a novel iron-based nanomaterial that targets and destroys cancer cells from within. Th
Study: Ozempic and Wegovy Reduce Household Food Spending and Change Purchasing Patterns
New research published in the Journal of Marketing Research shows that GLP-1 receptor agonist drugs like Ozempic and Wegovy are significantl
news.cornell.edu·4mo ago
Gemma-Based AI Model Identifies Potential Cancer Therapy Pathway Through Conditional Immune Amplification
Researchers used a new 27 billion parameter foundation model called C2S-Scale 27B, built on Google's Gemma family of open models, to discove
blog.google·7mo ago